Urgent Copper Stock With Strong Catalysts

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor
April 11, 2024

Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents.

Fastenal shares dipped 6.7% to $69.73 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Rallybio Corporation (NASDAQ:RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
  • Rent the Runway, Inc. (NASDAQ:RENT) shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance.
  • Eliem Therapeutics, Inc. (NASDAQ:ELYM) jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement.
  • Akanda Corp. (NASDAQ:AKAN) gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry.
  • Alpine Immune Sciences, Inc. (NASDAQ:ALPN) rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.
  • Candel Therapeutics, Inc. (NASDAQ:CADL) surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer.
  • Enliven Therapeutics, Inc. (NASDAQ:ELVN) gained 26% to $24.97. Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia.
  • Selina Hospitality PLC (NASDAQ:SLNA) rose 21.1% to $0.0923.
  • Globavend Holdings Limited (NASDAQ:GVH) climbed 16.8% to $1.68.
  • Janux Therapeutics, Inc. (NASDAQ:JANX) gained 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.
  • SciSparc Ltd. (NASDAQ:SPRC) shares rose 15.3% to $1.9357.
  • Gyre Therapeutics, Inc. (NASDAQ:GYRE) gained 14.6% to $15.91.
  • AnaptysBio, Inc. (NASDAQ:ANAB) climbed 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.
  • Verb Technology Company, Inc. (NASDAQ:VERB) gained 10.4% to $0.2010 after gaining 4% on Wednesday.
  • GigaCloud Technology Inc. (NASDAQ:GCT) rose 10.2% to $34.18.
  • Nurix Therapeutics, Inc. (NASDAQ:NRIX) gained 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.
  • StepStone Group LP (NASDAQ:STEP) rose 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.

Losers

  • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares fell 58% to $1.01 after the company priced its $4.6 million public offering.
  • Enlivex Therapeutics Ltd. (NASDAQ:ENLV) fell 54.5% to $1.81. The company announced topline results of its Phase II trial evaluating Allocetra in sepsis.
  • AVITA Medical, Inc. (NASDAQ:RCEL) fell 28.6% to $10.31 after the company announced an update to its expected commercial revenue for the first quarter of 2024. BTIG downgraded the stock from Buy to Neutral.
  • Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) fell 19% to $0.3723.
  • Globe Life Inc. (NYSE:GL) fell 14.6% to $89.65.
  • The Lovesac Company (NASDAQ:LOVE) shares fell 14.3% to $20.00 after the company reported worse-than-expected fourth-quarter results and issued first-quarter guidance.
  • Globe Life Inc. (NYSE:GL) fell 13.7% to $90.56.
  • Meiwu Technology Company Limited (NASDAQ:WNW) shares declined 12.4% to $1.1601 after jumping around 32% on Wednesday.
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 12% to $0.7660 after declining 14% on Wednesday. Acorda Therapeutics recently commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
  • CarMax, Inc. (NYSE:KMX) fell 11.7% to $70.02 after the company reported lower-than-expected fourth-quarter earnings.
  • VBI Vaccines Inc. (NASDAQ:VBIV) dipped 11.3% to $0.5641.
  • Nikola Corporation (NASDAQ:NKLA) fell 11.3% to $0.8680. On April 9, Wolfe Research analyst Scott Group initiated coverage on Nikola with a Peer Perform rating.
  • Marin Software Incorporated (NASDAQ:MRIN) declined 10.8% to $0.5798.
  • SolarBank Corporation (NASDAQ:SUUN) fell 9.3% to $5.29. SolarBank closed purchase of 3.15 MW solar project in New York from Storke Renewable.
  • Esperion Therapeutics, Inc. (NASDAQ:ESPR) fell 9.1% to $2.29.
  • 9F Inc. (NASDAQ:JFU) fell 8.8% to $2.7046.
  • iCoreConnect Inc. (NASDAQ:ICCT) shares fell 8.5% to $1.55 after jumping over 50% on Wednesday.
  • ClearOne, Inc. (NASDAQ:CLRO) declined 8.3% to $1.00. The company recently reported fourth-quarter financial results.
  • Nyxoah S.A. (NASDAQ:NYXH) fell 7.3% to $9.83
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 6.2% to $0.8164.
  • Walker & Dunlop, Inc. (NYSE:WD) fell 5.3% to $87.71 after Wedbush downgraded the stock from Outperform to Neutral and lowered its price target from $130 to $95.

 

Now Read This: Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

Continue Reading...

Popular

Cathie Wood Dumps $2.4 Million Worth Of Tesla Stock, Doubles Down On These AI Stocks

Cathie Wood-led Ark Invest made significant trades involving Tesla, Pony AI, TSMC, and Baidu, highlighting their strategic positioning in tech & AI sectors.

Space forecasters say severe solar storms could hit Earth and trigger auroras

NEW YORK (AP) — Space weather forecasters issued an alert on Tuesday for incoming severe that could produce and temporarily disrupt communications.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Indigenous groups get the spotlight at UN climate talks, but some say visibility isn't power

BELEM, Brazil (AP) — Indigenous people are used to adapting, so when the power failed at their kickoff event at this year's , they rolled with it. Participants from around the world sweated through song, dance and prayers, improvising without microphones and cooling themselves with fans made of paper or leaves.

Marjorie Taylor Greene Buys Blue Chip Stock Near 52-Week Low

Marjorie Taylor Greene is known for buying multiple stocks at a time, based on recent disclosures. A new filing shows one stock bought in November.

Copper, Silver, Gold, Tungsten - This Nevada Play Offers Multiple Shots on Goal - Ad

Most early-stage resource opportunities rely on one metal. This one doesn't. The Walker Lane belt hosts copper, silver, gold, and tungsten - and recent results across the district confirm all four. This startup has stepped in with multi-metal exposure, giving investors several potential ways to capture upside.

Asian shares are mostly lower despite Wall St rally and a potential end to the US shutdown

BANGKOK (AP) — Asian shares were mostly lower on Tuesday as the recent rebound fueled by buying of technology shares lost steam.

Nevada's Mining Renaissance Is Accelerating - And This Early Opportunity Is Well Positioned - Ad

Nevada's Walker Lane belt has produced 50M+ ounces of gold since the 1800s, and it's waking up again. One of the neighborhood's latest successes just secured over $6M in U.S. support and is up more than 300% YTD. Now a new early-stage explorer has moved in next door.

Swiss prosecutors target Credit Suisse, now part of UBS, over Mozambique money laundering case

GENEVA (AP) — Swiss authorities on Monday said they have indicted a former official at Credit Suisse — now part of Swiss banking titan UBS — for alleged money laundering in a case involving state companies in Mozambique, and charged the bank with not doing enough to stop it.

Cathie Wood Dumps $11.6 Million Worth Of Tesla Stock: Here Is What Ark Purchased Instead

On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.

Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad

AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.

Tax-Free Student Loan Forgiveness Expires In 2026, Who Owes More Next Year?

The American Rescue Plan Act of 2021 will make most student loan forgiveness tax-free until 2025, then borrowers may owe thousands in taxes.

New Number One Copper Start Alert - Ad

EVs and AI devour copper. Supply cannot keep up. A Quebec discovery with high grade, infrastructure, and cheap power is funded to drill through the year. Catalysts are lining up. Institutions are circling. Move now while it is still early.

In Trump-dominated media world, editing video takes on new significance — as BBC uproar shows

In the space of a few months, one of the more straightforward journalistic tasks — editing tape for broadcast — has been behind a $16 million legal settlement, a network's change in how it offers interviews on a news show and, now, the resignation of two top leaders at the BBC.

Rand Paul Slams GOP's Shift From Fiscal Conservatism: They Voted To Add '$5 Trillion' To The Debt Ceiling — Calls It 'Decimation'

Sen. Rand Paul (R-Ky.) slammed the Republican Party for abandoning the fiscal discipline it once championed, while accusing his colleagues of embracing massive governmental deficits and greenlighting spending levels they previously opposed.

First Drug to Show Breakthrough Myocarditis Data. Analysts See Potential 7-10x Upside. - Ad

This biotech just delivered a medical first in myocarditis and has a Phase 3 trial fully funded into 2027. Wall Street targets imply massive revaluation ahead.

Japan's SoftBank says it has sold its shares in Nvidia for $5.8 billion

TOKYO (AP) — Japanese technology company SoftBank Group Corp. said Tuesday that it has sold all the Nvidia Corp. shares that it owned for $5.83 billion, while it reported higher than expected profit in the first half of this fiscal year.

Elon Musk Says Tesla, xAI Are 'Trending Towards Convergence' In Some Ways

Elon Musk's companies could potentially merge in the future as he continues to integrate AI into his ventures.

The Next 'Ozempic Moment' Could Be in Heart Disease - Ad

Just as Ozempic rewrote the obesity playbook, this breakthrough data could transform how we treat inflammatory heart disease. Fully funded. Multiple catalysts. $280B market opportunity.

What's Going On With Papa John's (PZZA) Stock Today? (UPDATED)

Shares of Papa John's International, Inc. (NASDAQ: PZZA) moved higher on Monday. Here's what you need to know.

Trump Signs Law to Launch Dollar 2.0 - Ad

Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.

Dogecoin Fakes A Rally Then Dumps 3%—But Why?

Dogecoin (CRYPTO: DOGE) fell close to 3% on Tuesday, as large holders shifted roughly $32 million worth of DOGE to exchanges, putting sellers back in control.

Yemen's Houthi rebels signal that they've stopped attacks on Israel and Red Sea shipping

DUBAI, United Arab Emirates (AP) — Yemen’s Houthi rebels are signaling they’ve stopped their as a holds in the Gaza Strip.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

OpenAI's Partners Rake Up $96 Billion Debt as AI Industry's Borrowing Trend Escalates

Companies supplying data centers, chips, and processing power to OpenAI have racked up a staggering $96 billion in debt to fund their operations.

Donald Trump Administration's Unprecedented Investment In Private Firms Raises Eyebrows

President Trump administration has invested over $10 billion of taxpayer funds in private companies deemed crucial to national security.

Urgent Copper Stock With Strong Catalysts - Ad

Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.

Watchdog group Public Citizen demands OpenAI withdraw AI video app Sora over deepfake dangers

The tech industry is moving fast and breaking things again — and this time it is humanity’s shared reality and control of our likeness before and after death — thanks to artificial intelligence image-generation platforms .

Elon Musk Says SpaceX Will Carry '99% Of All Earth Payload' Once Starship Flies Daily

Elon Musk says SpaceX will handle nearly all of Earth's orbital payloads in the coming years as Starship development continues.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Swiss voters reject mandatory national service for women and new inheritance tax

GENEVA (AP) — Swiss voters on Sunday decisively rejected a call to require women to do national service in the military, civil protection teams or other forms, as all men must do already.

Axon Enterprise: From TASER To AI-Powered Public Safety Platform

Axon Enterprise is executing an interesting transition from hardware vendor to high-margin SaaS and AI platform...

Copper, Silver, Gold, Tungsten - This Nevada Play Offers Multiple Shots on Goal - Ad

Most early-stage resource opportunities rely on one metal. This one doesn't. The Walker Lane belt hosts copper, silver, gold, and tungsten - and recent results across the district confirm all four. This startup has stepped in with multi-metal exposure, giving investors several potential ways to capture upside.

Nvidia, Dell, Coinbase, Gorilla Technology And Archer Aviation: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed lower on Monday, with the Dow slipping 1.2% to 46,590.24, the S&P 500 easing 0.92% to 6,672.41, and the Nasdaq dipping 0.84% to 22,708.07. These are the top stocks that gained the attention of retail traders and investors through the day:

US Senate Discloses Landmark Crypto Market Structure Bill, Eyes Passage By Late 2025

Bitcoin (CRYPTO: BTC) is holding steady near $105,000 as markets digest the Senate's long-awaited crypto market structure bill draft, a major milestone toward regulatory clarity

Nevada's Mining Renaissance Is Accelerating - And This Early Opportunity Is Well Positioned - Ad

Nevada's Walker Lane belt has produced 50M+ ounces of gold since the 1800s, and it's waking up again. One of the neighborhood's latest successes just secured over $6M in U.S. support and is up more than 300% YTD. Now a new early-stage explorer has moved in next door.

Why Is Occidental Petroleum Stock Gaining Tuesday?

Analysts highlight OXY's robust earnings, production guidance, and expanded resource base as key growth drivers.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service